BIOMERICA INC. - COMMON STOCK

Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock

07 Mar 2023 16:39:57 By Nasdaq GlobeNewswire

Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock

03 Mar 2023 07:30:00 By Nasdaq GlobeNewswire

Biomerica Announces Proposed Underwritten Public Offering of Common Stock

02 Mar 2023 17:15:01 By Nasdaq GlobeNewswire

Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

13 Jan 2023 18:39:00 By Nasdaq GlobeNewswire

Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company’s Scientific Advisory Board

10 Jan 2023 08:19:00 By Nasdaq GlobeNewswire

Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE

08 Dec 2022 08:19:00 By Nasdaq GlobeNewswire

Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting

02 Nov 2022 08:19:00 By Nasdaq GlobeNewswire

Walmart to Expand Sales of Biomerica’s Aware® Breast Self Exam; Product will now be available in over 2400 Walmart stores

14 Oct 2022 09:18:00 By Nasdaq GlobeNewswire

Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022

13 Oct 2022 16:50:00 By Nasdaq GlobeNewswire

Biomerica’s Aware® Breast Self Exam and EZ Detect™ Colon Disease Test Now Available on Amazon and Fulfilled by Amazon

29 Sep 2022 08:19:00 By Nasdaq GlobeNewswire

Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer

30 Aug 2022 08:19:00 By Nasdaq GlobeNewswire

Biomerica Reports Fiscal 2022 Year End Results

29 Aug 2022 16:41:00 By Nasdaq GlobeNewswire

Walmart to Begin Selling Biomerica’s Aware® Breast Self Exam

14 Jul 2022 08:19:00 By Nasdaq GlobeNewswire

Biomerica to Participate at BTIG Biotech Conference

23 Jun 2022 08:19:00 By Nasdaq GlobeNewswire

Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™

12 May 2022 08:19:00 By Nasdaq GlobeNewswire

Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population

26 Apr 2022 08:19:00 By Nasdaq GlobeNewswire

Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021

14 Apr 2022 08:37:00 By Nasdaq GlobeNewswire

Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome

08 Feb 2022 06:39:00 By Nasdaq GlobeNewswire

Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021

13 Jan 2022 08:19:00 By Nasdaq GlobeNewswire

Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million

16 Dec 2021 08:19:00 By Nasdaq GlobeNewswire